This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, …

Ganglioneuroblastoma, NodularNeuroblastoma

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06172296

Phase 3

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or g…

GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma

~Estimated

~$10 – $7,500

Children's Oncology GroupNCT03126916